| Identification and Evaluation of Endogenous Markers for the Assessment of CYP3A Activity Using Metabolomics (NCT01215214) | Seoul National University Hospital | 2010-10-01 |
| A Safety and Pharmacokinetics Study of ASP0456 in Healthy Subjects (NCT01279915) | Astellas Pharma Inc | 2010-10-01 |
| Pasta Formulations, Portion Sizes and Their Effect on Appetite (NCT01199770) | Clinical Nutrition Research Center, Illinois Institute of Technology | 2010-09-15 |
| Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects (NCT01442831) | Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2010-09-09 |
| Comparative Bioavailability Study of an Immediate Release and Controlled Release Oral Formulations of Huperzine A (NCT01136551) | Hadassah Medical Organization | 2010-09-01 |
| A Drug Interaction Study of Warfarin and Canagliflozin in Healthy Adult Volunteers (NCT01195324) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-09-01 |
| Longitudinal 3He Magnetic Resonance Imaging of Healthy Lung (NCT02483403) | Western University, Canada | 2010-09-01 |
| LEO 22811 - Single Dose Bioavailability Study of Tablet Versus Oral Solution in Healthy Subjects (NCT01211964) | LEO Pharma | 2010-09-01 |
| Clinical Assessment of Barley and Oat Phytochemicals (NCT01303562) | Tufts University | 2010-09-01 |
| Effect Of Ketoconazole On The Pharmacokinetics Of Tasocitinib (CP-690,550) In Healthy Volunteers (NCT01202240) | Pfizer | 2010-09-01 |
| Relative Bioavailability of Two Different Batches of a Linagliptin / Metformin Combination Tablet in Healthy Volunteers (NCT01216397) | Boehringer Ingelheim | 2010-09-01 |
| Heart Rate Changes During Normal Activity, Exercise, and Sleep in Normal Healthy Subjects With and Without Epilepsy (NCT01202682) | Cyberonics, Inc. | 2010-09-01 |
| A Pharmacokinetics and Safety of Methylphenidate HCl in Healthy Japanese Adult Male Volunteers (NCT01202734) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-09-01 |
| Pharmacokinetics/Pharmacodynamics (PK/PD) of Multiple Oral Doses of GLPG0555 in Healthy Subjects (NCT01208753) | Lakefront Biotherapeutics NV | 2010-09-01 |
| First-in-Man Trial of NNC114-0005 in Healthy Subjects and Subjects With Rheumatoid Arthritis (NCT01208506) | Novo Nordisk A/S | 2010-09-01 |
| Vitamin D Deficiency in Adolescent Girls (NCT01180946) | Massachusetts General Hospital | 2010-09-01 |
| Safety Study of Inhaling Carbon Monoxide in Healthy Volunteers (NCT01050933) | Queen's University | 2010-09-01 |
| To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Administration of AZD8329 (NCT01207089) | AstraZeneca | 2010-09-01 |
| Development of Field Test for Assessing the Human Anaerobic Capability (NCT01139684) | Hillel Yaffe Medical Center | 2010-09-01 |
| A PET Study to Determine Alterations in Serotonin Levels in Human Brain After a Single Dose of Escitalopram (NCT01638689) | Karolinska Institutet | 2010-09-01 |
| Measurement of Echogenic Area in the Border of the Fetal Ventricles (NCT01178606) | Meir Medical Center | 2010-09-01 |
| The Effect of Vitamin D Fortification of Bread and Milk in Danish Families (NCT01184716) | Technical University of Denmark | 2010-09-01 |
| The Effect of Hypertrophic Pyloric Stenosis (HPS) on Sodium Intake in Childhood (NCT01159509) | Sheba Medical Center | 2010-09-01 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of Modified-Release Formulations of AZD1446 After Oral Single and Repeated Doses (NCT01199315) | AstraZeneca | 2010-09-01 |
| A Phase I Trial to Investigate the Metabolism and Pharmacokinetics as Well as Safety and Tolerability of a Single Dose BI671800 HEA Administered as an Oral Solution of the Choline Salt in Healthy Male Volunteers (NCT01205373) | Boehringer Ingelheim | 2010-09-01 |
| Study In Healthy Subjects To Evaluate The Changes In The Protein sAPP-Alpha In Cerebrospinal Fluid Following A Single Oral Dose Of PF-04995274 (NCT01193062) | Pfizer | 2010-09-01 |
| Importance of the GH/IGF-1 Axis for Human Substrate and Energy Metabolism During Calorie Restriction (NCT01209429) | University of Aarhus | 2010-09-01 |
| The Effect Of Berry Polyphenols On Human Behaviour (NCT01507012) | Northumbria University | 2010-09-01 |
| Lamotrigine Extended-Release Tablets 50 mg Under Fed Condition (NCT01888757) | Dr. Reddy's Laboratories Limited | 2010-09-01 |
| Safety and Tolerability of BI 638683 After Single Rising Oral Doses in Healthy Male Subjects (NCT01195688) | Boehringer Ingelheim | 2010-09-01 |
| The Validity of Retinal Blood Flow Measurements During Hyperoxia in Humans Using Fourier Domain Color Doppler Optical Coherence Tomography (CDOCT) (NCT00431600) | Medical University of Vienna | 2010-09-01 |
| Safety and Tolerability of Single and Multiple Intravenous Doses of Finafloxacin in Healthy Subjects (NCT01910883) | MerLion Pharmaceuticals GmbH | 2010-09-01 |
| A Clinical Pharmacological Study of Rabeprazole Sodium in Japanese Healthy Adult Male Volunteers (Study E3810) (NCT01202071) | Eisai Co., Ltd. | 2010-09-01 |
| A Study to Assess the Bioavailability of ASP015K (NCT01430078) | Astellas Pharma Inc | 2010-09-01 |
| A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan (NCT01197014) | Hanmi Pharmaceutical Company Limited | 2010-09-01 |
| Estimate The Effect Of Repeat-Dose Rifampin On The Pharmacokinetics Of CP-690,550 In Healthy Volunteers (NCT01204112) | Pfizer | 2010-09-01 |
| Caloric Titration Method of Weight Loss and Maintenance (NCT03553160) | Cornell University | 2010-08-16 |
| Acute Response Capsaicin Flare Study (NCT01147432) | Pfizer | 2010-08-01 |
| The Metabolic Effect of Walnut Consumption in Healthy Men and Healthy Postmenopausal Women (NCT01188902) | Ludwig-Maximilians - University of Munich | 2010-08-01 |
| Positive Effects of Haematococcus Astaxanthin on Oxidative Stress and Lipid Profile in Overweight and Obese Adults (NCT01167205) | Seoul National University Hospital | 2010-08-01 |
| Bioequivalence Study of Lamotrigine Extended-Release Tablets 200mg Under Fed Condition (NCT01888263) | Dr. Reddy's Laboratories Limited | 2010-08-01 |
| Single Dose Study Of PF-04308515 And Prednisone On Carbohydrate (NCT01199029) | Pfizer | 2010-08-01 |
| Target Site Pharmacokinetics of Doripenem After a Single Dose of 500mg in Healthy Volunteers Dori_MD_1 (NCT01311141) | Medical University of Vienna | 2010-08-01 |
| A Phase 1 Absolute Bioavailability Study For Oral Crizotinib In Healthy Volunteers (NCT01168934) | Pfizer | 2010-08-01 |
| Bioequivalence Study of Lamotrigine Extended-Release Tablets 50 mg Under Fasting Condition (NCT01888731) | Dr. Reddy's Laboratories Limited | 2010-08-01 |
| To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding In Brain Using PET (Positron Emission Tomography) In Healthy Volunteers (NCT01173757) | Pfizer | 2010-08-01 |
| A Drug Interaction Study of 31001074 and Paroxetine in Healthy Volunteers (NCT01159821) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-08-01 |
| Telmisartan, Amlodipine and Combination in Healthy Subjects (NCT01181011) | Boehringer Ingelheim | 2010-08-01 |
| Pharmacodynamics of Lorelin Depot (Leuprorelin Acetate - Bergamo) Compared to Lupron Depot ® (Leuprorelin Acetate - Abbot) (NCT01071005) | Azidus Brasil | 2010-08-01 |
| First-in-Human Single Ascending and Multiple Dose of GLPG0634 (NCT01179581) | Lakefront Biotherapeutics NV | 2010-08-01 |
| A Study of Canagliflozin in Study Participants With Various Degrees of Impaired Hepatic (Liver) Function (NCT01186588) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-08-01 |
| Ascending Dose Study of the Safety and Tolerability of REGN728 in Healthy Volunteers (NCT01197391) | Regeneron Pharmaceuticals | 2010-08-01 |
| Pharmacokinetics (PK) of Ertapenem Intravenous (IV) Bolus Versus Standard Infusion (NCT01148771) | Hartford Hospital | 2010-08-01 |
| Cheek Cells - Non-invasive Fatty Acid Status Marker (NCT01192269) | Ludwig-Maximilians - University of Munich | 2010-08-01 |
| A Relative Bioavailability Study of Rabeprazole Sodium Administered With Different Dosing Vehicles in Healthy Adult Volunteers (NCT01186497) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-08-01 |
| Pharmacokinetics And Safety Study Of Two CP-690,550 Controlled Release Formulation Following Single Dose In Healthy Volunteers (NCT01185184) | Pfizer | 2010-08-01 |
| A Clinical Study Evaluating The Safety And Tolerability Of PF-04427429 In Healthy Adult Volunteers. The Pharmacokinetics And Pharmacodynamics Of PF-04427429 Will Also Be Investigated (NCT01165723) | Pfizer | 2010-08-01 |
| A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan (NCT01197001) | Hanmi Pharmaceutical Company Limited | 2010-08-01 |
| A Study To Observe Safety And Blood Concentrations Of PF-04995274 During And Following the Administration of Multiple Doses Of PF-04995274 In Healthy Adult And Healthy Elderly Volunteers. (NCT01169714) | Pfizer | 2010-08-01 |
| Bioequivalence And Food Effect Study Comparing The Commercial Formulation Of Crizotinib To Its Clinical Study Formulations And Commercial Formulation With Or Without Food In Healthy Volunteers (NCT01154218) | Pfizer | 2010-08-01 |
| Comparison of Two Identical NN1250 Formulations in Healthy Volunteers (NCT01193387) | Novo Nordisk A/S | 2010-08-01 |
| Safety and Tolerability Study of N6022 in Healthy Subjects (NCT01147406) | Nivalis Therapeutics, Inc. | 2010-08-01 |
| Rel. BA of Empagliflozin (BI 10773)/Linagliptin FDC Tbl, Comparison With Mono-components, With a Second FDC Tablet and Influence of Food (NCT01189201) | Boehringer Ingelheim | 2010-08-01 |
| Bioequivalence Study of Lamotrigine Extended-Release Tablets 200mg Under Fasting Condition (NCT01888250) | Dr. Reddy's Laboratories Limited | 2010-08-01 |
| Single Dose Study Of PF-04171327 And Prednisone On Carbohydrate Metabolism (NCT01199900) | Pfizer | 2010-08-01 |
| Control of Center of Mass to Predict Balance Ability and Fall Risks in Elderly (NCT01504217) | National Taiwan University Hospital | 2010-08-01 |
| Assessment of the Effect of Empagliflozin (BI 10773) as Single Dose on the QT Interval in Healthy Female and Male Subjects (NCT01195675) | Boehringer Ingelheim | 2010-08-01 |
| QT Intervals Study to Compare the Acute Effects of Orally Inhaled Dihydroergotamine (DHE), Oral Moxifloxacin, and Placebo (NCT01191723) | Allergan | 2010-08-01 |
| Acute Vascular Response To Meals Varying In Glycemic Index And Glycemic Load (NCT01883700) | Unity Health Toronto | 2010-08-01 |
| Safety and Performance Evaluation of the Rapid Ring Device (NCT01152983) | RapiDx Ltd. | 2010-08-01 |
| Study in Healthy Male Subjects to Investigate Whether Ketoconazole Affects Plasma Exposure of BI 113823 (NCT01189175) | Boehringer Ingelheim | 2010-08-01 |
| Study Of VGX-3400, H5N1 Avian Flu Virus Plasmid DNA With Electroporation Device In Healthy Adult Males (NCT01184976) | GeneOne Life Science, Inc. | 2010-08-01 |
| A Study Of Two Oral Preparations Of 2 Mg Alprazolam In Healthy Volunteers Under Fasting Conditions (NCT01046162) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-07-15 |
| Phyllantus Amarus for the Protection of Liver Health (NCT03349697) | Biotropics Malaysia Berhad | 2010-07-13 |
| Bioequivalence of a Fixed Dose Combination Tablet Containing 200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl Compared to RhinAdvil(R)(200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl) as a Fixed Dose Combination Tablet Administered in Healthy Volunteers. (NCT01170637) | Boehringer Ingelheim | 2010-07-01 |
| Pharmacokinetics, Safety and Tolerability Study of PF-03463275 in Healthy Male Japanese and Western Subjects (NCT01159626) | Pfizer | 2010-07-01 |
| Biopharmaceutical Study of Glyco pMDI With or Without Charcoal Block vs IV Bolus in Healthy Volunteers (NCT01176851) | Chiesi Farmaceutici S.p.A. | 2010-07-01 |
| Oral Mucosal Absorption Study of Bicalutamide New Formulation (NCT01416883) | AstraZeneca | 2010-07-01 |
| Study to Investigate Multiple Ascending Oral Doses of AZD5213 in Healthy Male and Non Fertile Female Subjects (NCT01171105) | AstraZeneca | 2010-07-01 |
| To Calculate the Pharmacokinetics (Concentration of Compound in and Rate of Excretion From the Blood) Following a Very Low Dose of Compound Which Will Not Have Any Pharmacological Activity (NCT01165736) | Pfizer | 2010-07-01 |
| To Investigate Safety, Tolerability and Pharmacokinetics of TC-5214 in Healthy Male Japanese Subjects (NCT01175564) | AstraZeneca | 2010-07-01 |
| Eletriptan Pharmacokinetics In Korean Males (NCT01139515) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-07-01 |
| Estimation Of Effect Of Rifampin On Pharmacokinetics Of Crizotinib In Healthy Volunteers (NCT01147055) | Pfizer | 2010-07-01 |
| Clinical Study to Investigate Safety and Tolerability and Pharmacokinetics of Multiple Ascending Doses of CM3.1-AC100 in Healthy Male Volunteers (NCT01165502) | CellMed AG, a subsidiary of BTG plc. | 2010-07-01 |
| Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects (NCT01140412) | ViiV Healthcare | 2010-07-01 |
| A Study to Evaluate the Effect on 24-hour, Intragastric pH of RAB ER 50-mg Capsules Compared With Esomeprazole (Nexium) 40 mg Capsules and Rabeprazole (Aciphex) 20-mg Tablets (NCT01153659) | Eisai Inc. | 2010-07-01 |
| A Pivotal Study to Evaluate the Bio-equivalence of the Tapentadol Extended-Release (ER) Tamper-resistant Formulation (TRF) Tablet to the Current Tapentadol ER Prolonged-release 2 (PR2) Tablet (NCT01900587) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-07-01 |
| Multiple Ascending Dose Study To Assess Safety, Tolerability And Pharmacokinetics Of PF-05212377 (SAM-760) (NCT01159496) | Pfizer | 2010-07-01 |
| Bioequivalence Study Of Phenytoin Suspension Versus Epamin® In 34 Healthy Volunteers. (NCT01122940) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-07-01 |
| A Study To Estimate The Amount Of CP-690,550 (Study Drug) That Is Absorbed Into The Blood Of Healthy Subjects Following Oral Administration Of CP-690,550 In Tablet Form (NCT01143805) | Pfizer | 2010-07-01 |
| Drug-Drug Interaction Study to Assess the Effects of Steady State Pitavastatin 4 mg or Rosuvastatin 40 mg on Steady-State Warfarin in Healthy Adult Volunteers (NCT01178853) | Kowa Research Institute, Inc. | 2010-07-01 |
| Pharmacokinetics of Empagliflozin (BI 10773) in Patients With Impaired Liver Function (NCT01111318) | Boehringer Ingelheim | 2010-07-01 |
| A Study to Assess Bioequivalence of a New Tapentadol Extended-Release 250-mg Tablet With Respect to a Tapentadol Extended-Release 250-mg Tablet in Healthy Participants (NCT01981278) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-07-01 |
| Non-invasive Ocular Surface Measurements Before and After Interventions (NCT01228929) | University of Rochester | 2010-07-01 |
| A Study to Assess Bioequivalence of a New Tapentadol Extended-Release Tablet With Respect to a Tapentadol Extended Release Tablet Under Fasted Conditions in Healthy Subjects (NCT02019485) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-07-01 |
| Bioequivalence of Bicalutamide New Formulation in Japan (NCT01416870) | AstraZeneca | 2010-07-01 |
| Estimation Of Effect Of Ketoconazole On Pharmacokinetics Of Crizotinib In Healthy Volunteers (NCT01149785) | Pfizer | 2010-07-01 |
| A Study to Assess the Safety, Tolerability, and Blood and Urine Drug Levels of Fostamatinib Disodium (FosD) in Healthy Japanese and White Subjects (NCT01167868) | AstraZeneca | 2010-07-01 |
| Resveratrol and Midazolam Metabolism (NCT01173640) | University of Washington | 2010-07-01 |
| A Study to Evaluate the Drug Interaction of ASP015K and Tacrolimus (NCT01190670) | Astellas Pharma Inc | 2010-07-01 |